My Shining Light

No Need For Health Concerns

How Oncotarget is Collaborating with Pubmed in Publishing Two Articles Per Week

Oncotarget is the leading publisher of materials in the field of oncology. The journal was established by Dr. Mikhail Blagosklonny and his colleague Andrei V. Gudkov. This open access journal has been operational since 2010. Oncotarget publishes research papers on a weekly basis. This journal recently published an article on the attitudes towards electronic cigarettes. Learn more about Oncotarget at Research Gate.

Uses of e-cigarettes

According to the researchers who conducted this study, the use of e-cigarettes has been on the rise among young people. Benjamin Reinhold and his co-workers set out to investigate the addictiveness, perceptions of harm, and acceptability of e-cigarettes. The study involved 6037 students at Midwestern University. Findings from this research work revealed that e-cigarette use had risen due acceptability of use in places where traditional cigarettes are banned. Increased use is also attributed to the belief that e-cigarettes cause minimal harm than the conventional ones.

Oncotarget launches the second issue

In a recent interview with PR Newswire, Oncotarget officials revealed that this journal’s publications would continue to be featured on ISI/Web of Science: Science Citation Index Expanded and PubMed. They will also be available at Biological Abstracts, Scopus, EMBASE, and BIOSIS Previews. Oncotarget is known to work in collaboration with archives and high profile indexes. This collaboration is aimed at making new knowledge available to the general public, medical researchers, and other practitioners. Oncotarget has also resulted in publishing two articles in a week to increase its indexing processes.

Aside from oncology, Oncotarget publishes articles in the field of autophagy, immunology, microbiology, aging, chromosomes, and pathology. Since it was launched, Oncotarget has published more than 324 papers contained in seven volumes. This journal is unique in the way it marks its articles. Oncotarget uses a direct object identifier (DOI) to all its documents. This technique is in line with the recommendations championed by the Committee on Publication Ethics (COPE). Check Oncotarget journal at

According to Oncotarget’s office of external & legal affairs, the journal is committed to solving the challenges of the 21st Century. They also added that Oncotarget is created by scientists for the scientists interested in making a difference in the society. Oncotarget dedication to fighting disease is what makes it exceptional.